Skip to main content
. 2010 Jun 17;285(36):28164–28173. doi: 10.1074/jbc.M110.101964

FIGURE 1.

FIGURE 1.

Schematic representation of the experimental design. huRANKL mice were ovariectomized (OVX) or not (Sham) at 18 weeks of age and assigned to receive either Veh, Aln, or DMAb treatment. After 4 weeks, mice were further assigned to intermittent PTH (1–34) (80 μg/kg/day) or Veh administration, in addition to Aln, DMAb, or Veh.